微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 3.19% | -10.64% | 42.41% | 89/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 2.24% | -11.46% | 115.38% | 81/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.04% | -50.71% | -51.17% | 87/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 2.13% | -61.34% | -40.34% | 86/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 3.57% | -61.32% | 41.11% | 78/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.53% | 3.69% | 19.91% | 72/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.11% | 0.96% | -61.71% | 54/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 5.51% | 9.76% | -40.3% | 56/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 9.23% | 65.41% | 278.28% | 30/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.44% | 6.55% | 16.75% | 74/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.09% | 54.81% | -58.37% | 56/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.02% | 92.34% | -10.04% | 63/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.58% | 101.44% | 143.67% | 61/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.29% | 112.04% | 69.63% | 78/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.35% | -0.74% | -48.28% | 75/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.61% | 137.27% | -5.78% | 93/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.77% | 7.78% | 156.48% | 88/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.08% | -35.33% | -20.59% | 103/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.36% | -4.23% | 23.64% | 75/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.1% | 223.53% | -57.2% | 107/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 2.57% | -64.99% | 53.89% | 99/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.67% | 1570% | 17.61% | 103/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.42% | 610% | 317.65% | 81/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.34% | -84.04% | -95.37% | 109/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.34% | 114.62% | 7240% | 53/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.1% | -95.63% | -50% | 109/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 0.2% | -87.8% | -90.61% | 84/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.13% | -46.21% | -37.72% | 106/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 3.42% | -38.04% | 49.34% | 83/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.29% | -46.74% | 39.63% | 80/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.64% | -63.8% | -58.59% | 65/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.96% | 1.02% | -28.26% | 96/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.52% | 137.93% | 28.37% | 62/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.3% | 211.59% | -5.08% | 50/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.53% | 538.03% | 15.56% | 13/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.92% | 295.96% | 68.97% | 93/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.32% | 96.61% | 68.12% | 82/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.38% | 187.5% | 94.37% | 87/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.71% | 208.7% | -28.28% | 70/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 0.99% | 167.81% | -16.1% | 98/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.18% | 2260% | 145.83% | 74/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 0.48% | 173.85% | 108.7% | 80/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.23% | 9.52% | 115.75% | 72/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |